121 related articles for article (PubMed ID: 6520648)
1. Paranodal tumour in breast cancer: extranodal extension versus vascular spread.
Hartveit F
J Pathol; 1984 Dec; 144(4):253-6. PubMed ID: 6520648
[TBL] [Abstract][Full Text] [Related]
2. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
[TBL] [Abstract][Full Text] [Related]
3. Node-related factors and survival in node-positive breast carcinomas.
Sivridis E; Giatromanolaki A; Galazios G; Koukourakis MI
Breast; 2006 Jun; 15(3):382-9. PubMed ID: 16135406
[TBL] [Abstract][Full Text] [Related]
4. Prognosis in breast cancer patients with tumour cells in the efferent vessels of their axillary nodes.
Hartveit F; Skjaerven R; Maehle BO
J Pathol; 1983 Mar; 139(3):379-82. PubMed ID: 6834179
[TBL] [Abstract][Full Text] [Related]
5. Breast carcinoma grading, estimation of tumor size, axillary lymph node status, staging, and nottingham prognostic index scoring on mastectomy specimens.
Ahmad Z; Khurshid A; Qureshi A; Idress R; Asghar N; Kayani N
Indian J Pathol Microbiol; 2009; 52(4):477-81. PubMed ID: 19805950
[TBL] [Abstract][Full Text] [Related]
6. Paranodal vascular spread in breast cancer with axillary node involvement.
Hartveit F
J Pathol; 1979 Mar; 127(3):111-4. PubMed ID: 469636
[TBL] [Abstract][Full Text] [Related]
7. Node-positive breast cancer: axillary micrometastases, their incidence and some implications.
Hartveit F
Invasion Metastasis; 1996; 16(6):317-21. PubMed ID: 9371231
[TBL] [Abstract][Full Text] [Related]
8. [Very slight chance of other metastases in axillary nodes of breast cancer patients with a small sentinel node metastasis without extranodal tumor growth].
van der Loo EM; Hop WC; Tervoort MA; de Graaf PW
Ned Tijdschr Geneeskd; 2004 May; 148(19):938-43. PubMed ID: 15160561
[TBL] [Abstract][Full Text] [Related]
9. Extranodal extension of axillary metastasis of invasive breast carcinoma as a possible predictor for the total number of positive lymph nodes.
Palamba HW; Rombouts MC; Ruers TJ; Klinkenbijl JH; Wobbes T
Eur J Surg Oncol; 2001 Dec; 27(8):719-22. PubMed ID: 11735167
[TBL] [Abstract][Full Text] [Related]
10. Efferent vascular invasion and the mean nuclear area of axillary nodal tumour cells in breast cancer.
Maehle BO; Skjaerven R; Hartveit F
Diagn Histopathol; 1982; 5(4):297-300. PubMed ID: 7168996
[TBL] [Abstract][Full Text] [Related]
11. [The prognostic significance of axillary node metastasis in breast cancer].
Miura S
Gan To Kagaku Ryoho; 1996 Mar; 23 Suppl 1():36-42. PubMed ID: 8702309
[TBL] [Abstract][Full Text] [Related]
12. Early recurrence in breast cancer with efferent vascular invasion: a preliminary report.
Hartveit F; Støa KF; Tangen M
Invest Cell Pathol; 1980; 3(2):141-5. PubMed ID: 7380665
[TBL] [Abstract][Full Text] [Related]
13. Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer.
Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
Clin Cancer Res; 2003 Nov; 9(14):5313-7. PubMed ID: 14614015
[TBL] [Abstract][Full Text] [Related]
14. The lymph node ratio as prognostic factor in node-positive breast cancer.
Voordeckers M; Vinh-Hung V; Van de Steene J; Lamote J; Storme G
Radiother Oncol; 2004 Mar; 70(3):225-30. PubMed ID: 15064006
[TBL] [Abstract][Full Text] [Related]
15. Determinants of axillary recurrence after axillary lymph node dissection for invasive breast cancer.
Voogd AC; de Boer R; van der Sangen MJ; Roumen RM; Rutten HJ; Coebergh JW
Eur J Surg Oncol; 2001 Apr; 27(3):250-5. PubMed ID: 11373100
[TBL] [Abstract][Full Text] [Related]
16. The correlation of extranodal invasion with other prognostic parameters in lymph node positive breast cancer.
Altinyollar H; Berberoğlu U; Gülben K; Irkin F
J Surg Oncol; 2007 Jun; 95(7):567-71. PubMed ID: 17226805
[TBL] [Abstract][Full Text] [Related]
17. Tumour size as a predictor of axillary node metastases in patients with breast cancer.
Laura S; Coombs NJ; Ung O; Boyages J
ANZ J Surg; 2006 Nov; 76(11):1002-6. PubMed ID: 17054550
[TBL] [Abstract][Full Text] [Related]
18. Can clinically relevant prognostic subsets of breast cancer patients with four or more involved axillary lymph nodes be identified through immunohistochemical biomarkers? A tissue microarray feasibility study.
Crabb SJ; Bajdik CD; Leung S; Speers CH; Kennecke H; Huntsman DG; Gelmon KA
Breast Cancer Res; 2008; 10(1):R6. PubMed ID: 18194560
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of residual breast disease and axillary node involvement for patients who had primary induction chemotherapy for advanced breast cancer.
Escobar PF; Patrick RJ; Rybicki LA; Hicks D; Weng DE; Crowe JP
Ann Surg Oncol; 2006 Jun; 13(6):783-7. PubMed ID: 16604475
[TBL] [Abstract][Full Text] [Related]
20. The significance of one positive axillary node.
Kuijt GP; van de Poll-Franse LV; Roumen RM; van Beek MW; Voogd AC
Eur J Surg Oncol; 2006 Mar; 32(2):139-42. PubMed ID: 16412602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
